Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Carotid revascularization · Maine | Carotid revascularization · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 0 | 23 |
| Medicare fee-for-service cases | 161 | 1,666 |
| Growth since 2019 (Medicare FFS) | −5.5%/yr | −3.1%/yr |
| Forecast cases (Medicare FFS) | 670 in 2030 | 1,760 in 2030 |
| Forecast growth | +27%/yr to 2030 | +0.9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.0 | 1.2 |
| Medicare Advantage share | 62% | 58% |
| Out of hospital | 0% (+0 pts since 2021) | 0% (+0 pts since 2019) |
| Cases per surgeon | – | 72 |
| Top 10 surgeons' share | – | 59% |
| Surgeons growing | 0 | 0 |
| New since the base year | 0 | 5 |
| Likely to stop billing it | 0 by 2026 | 11 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | – | $5,363 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.